Status:
UNKNOWN
Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder
Lead Sponsor:
Institute of Child Health
Conditions:
Efficacy of PEGASUS
Eligibility:
All Genders
9-14 years
Phase:
NA
Brief Summary
When a clinician gives an autism spectrum disorder (ASD) diagnosis they hope this will be helpful to the person receiving it and their family. In reality children with an ASD describe few benefits to ...
Eligibility Criteria
Inclusion
- Received an ASD diagnosis from Child and Adolescent Psychiatrist, Clinical Psychologist or Paediatrician.
- Aware of ASD diagnosis.
- Aged between 9 and 14 years.
- Able to function in group setting, as evidenced in educational context.
- Speaks English
Exclusion
- No generalised Intellectual Disability as indicated by IQ below 65.
- Not engaged in additional formal psychosocial intervention during study period.
- Not taking psychiatric medication at baseline assessment, or taking a stable dose of psychiatric medication expected to remain constant throughout study participation.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01187940
Start Date
September 1 2010
Last Update
August 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Child Health
London, United Kingdom, WC1N 1EH